Teladoc Health, Inc.

Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: Teladoc Health, Inc. |
Ticker: | Ticker: TDOC |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE:TDOC). The investigation concerns whether Teladoc and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On February 20, 2025, Blue Orca Capital published a report (the “Report”) alleging that Teladoc has misled investors about its BetterHelp platform and financial reporting. The Report claims that BetterHelp has used AI-generated responses in place of licensed therapists without proper disclosures to patients. Furthermore, the Report accuses Teladoc of inflating profitability by shifting R&D expenses. On this news, the price of Teladoc shares declined by $1.08 per share, from $13.77 per share on February 19, 2025, to close at $12.69 on February 20, 2025.
On February 20, 2025, Blue Orca Capital published a report (the “Report”) alleging that Teladoc has misled investors about its BetterHelp platform and financial reporting. The Report claims that BetterHelp has used AI-generated responses in place of licensed therapists without proper disclosures to patients. Furthermore, the Report accuses Teladoc of inflating profitability by shifting R&D expenses. On this news, the price of Teladoc shares declined by $1.08 per share, from $13.77 per share on February 19, 2025, to close at $12.69 on February 20, 2025.